𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases

✍ Scribed by Carey K. Anders; Allison M. Deal; C. Ryan Miller; Carmen Khorram; Hong Meng; Emily Burrows; Chad Livasy; Karen Fritchie; Matthew G. Ewend; Charles M. Perou; Lisa A. Carey


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
198 KB
Volume
117
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Breast cancer subtypes and response to s
✍ Anna NiwiΕ„ska; Magdalena Murawska; Katarzyna Pogoda πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 182 KB πŸ‘ 2 views

## Abstract ## BACKGROUND: The aim of this study was to assess the role of systemic treatment after whole‐brain radiotherapy (WBRT) in immunohistochemically defined biological subsets of breast cancer patients with brain metastases. ## METHODS: The group of 420 consecutive breast cancer patients

Evaluation of 2 whole-brain radiotherapy
✍ Dirk Rades; Radka Lohynska; Theo Veninga; Lukas J. A. Stalpers; Steven E. Schild πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The majority of breast cancer patients with brain metastases receive whole‐brain radiotherapy (WBRT) and have a survival of only a few months. A short WBRT regimen would be preferable if it provides survival that is similar to that achieved with longer programs. This retr

Survival in patients with brain metastas
✍ April F. Eichler; Irene Kuter; Paula Ryan; Lidia Schapira; Jerry Younger; John W πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 183 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Brain metastases (BM) are the most common intracranial tumors in adults. To the authors' knowledge, established prognostic factors for survival after the diagnosis of BM in breast cancer patients do not take into account HER–2 status, which may have increasing relevance i